Advertisement

Treating limited-stage nodular lymphocyte predominant Hodgkin lymphoma similarly to classical Hodgkin lymphoma with ABVD may improve outcome

Kerry J. Savage, Brian Skinnider, Mubarak Al-Mansour, Laurie H. Sehn, Randy D. Gascoyne and Joseph M. Connors

Article Information

Citation 
vol. 118 no. 17 4585-4590
PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted July 7, 2011
  • Accepted August 17, 2011
  • Published online October 27, 2011.

Article Versions


Contributors 
  • Kerry J. Savage, 1Centre for Lymphoid Cancer and Department of Medical Oncology, British Columbia Cancer Agency and the University of British Columbia, Vancouver, BC; and
  • Brian Skinnider, 2Centre for Lymphoid Cancer and Department of Pathology, British Columbia Cancer Agency, Vancouver, BC
  • Mubarak Al-Mansour, 1Centre for Lymphoid Cancer and Department of Medical Oncology, British Columbia Cancer Agency and the University of British Columbia, Vancouver, BC; and
  • Laurie H. Sehn, 1Centre for Lymphoid Cancer and Department of Medical Oncology, British Columbia Cancer Agency and the University of British Columbia, Vancouver, BC; and
  • Randy D. Gascoyne, 2Centre for Lymphoid Cancer and Department of Pathology, British Columbia Cancer Agency, Vancouver, BC
  • Joseph M. Connors, 1Centre for Lymphoid Cancer and Department of Medical Oncology, British Columbia Cancer Agency and the University of British Columbia, Vancouver, BC; and

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output